Utah Medical Products, Inc. (UTMD) Cash Flow Statement
Utah Medical Products, Inc. (UTMD) generated $11.8M of operating cash flow over the twelve months to 2026-06-30, spent $400000 on capital expenditure and had free cash flow of $11.4M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
UTMDUtah Medical Products, Inc.Follow UTMD — free
—
Price chart with a free account
- Market cap
- 236.3M
- P/E TTM
- 22.6
- Dividend yield
- 1.7%
- 52-week
- —
- Next earnings
- 27 Oct, in 3 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 11.4 | 13.6 | 12.3 | 15.4 | 13.8 | 14.5 | 16.9 | 16.8 | 17.1 | 20.1 | 21.2 | 21.1 | 22.3 | 14.8 | 14.7 | 11.8 | |
| Capital expenditure | 0.2 | 0.3 | 0.3 | 1.1 | 0.2 | 3.3 | 1.6 | 0.4 | 0.5 | 0.9 | 0.6 | 0.8 | 0.6 | 0.2 | 0.4 | -0.4 | |
| Free cash flow | 11.1 | 13.3 | 12.0 | 14.3 | 13.6 | 11.2 | 15.3 | 16.4 | 16.5 | 19.3 | 20.7 | 20.3 | 21.6 | 14.6 | 14.3 | 11.4 | |
| Dividends paid | 3.4 | 3.6 | 3.7 | 3.8 | 3.8 | 3.9 | 3.0 | 4.0 | 4.1 | 4.1 | 11.5 | 3.2 | 4.3 | 4.3 | 4.0 | — | |
| Share repurchases | — | — | — | — | — | — | — | — | 0.4 | 7.0 | 0.0 | 2.5 | 0.0 | 20.0 | 8.4 | — | |
| Stock-based compensation | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.4 | — |
USD millions · SEC XBRL
Utah Medical Products, Inc. — questions
- What is Utah Medical Products, Inc.'s operating cash flow?
- $11.8M over the twelve months to 2026-06-30.
- How much does Utah Medical Products, Inc. spend on capital expenditure?
- $400000 over the twelve months to 2026-06-30.
- What is Utah Medical Products, Inc.'s free cash flow?
- $11.4M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Utah Medical Products, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.